Virtual ACC: Positive data for Medtronic’s Evolut TAVI system in low-risk patients with bicuspid aortic valve stenosis

Late-breaking data presented at the American College of Cardiology together with World Congress of Cardiology Scientific Sessions (ACC.20/WCC) virtual meeting (28–30 March, Central Time) show that transcatheter aortic valve implantation (TAVI) with the Evolut device (Medtronic) in low-risk patients with bicuspid aortic valves is associated with low rates of all-cause mortality or stroke at [...]

2020-04-02T11:56:58+00:00April 2nd, 2020|Tags: , , , |

CMS’ update to coverage policy for TAVI provides greater flexibility for hospitals and providers

The Centers for Medicare & Medicaid Services (CMS) has finalised its update the US coverage for transcatheter aortic valve implantation (TAVI). It will continue to provide coverage with evidence development when furnished according to an FDA-approved indication. However, it has updated the coverage criteria for hospitals and physicians to begin or maintain a TAVI [...]

2019-06-28T16:03:14+00:00June 24th, 2019|Tags: , , , |
Go to Top